NVACW Profusa, Inc.

BEARISH Impact: 6/10 8-K
Horizon weeks Filed Jun 8, 2026 Processed 1d 20h ago SEC 0001213900-26-066018
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Executive Summary

Profusa submitted an Advance Notice to Ascent Partners Fund LLC under an existing equity line of credit, requesting share purchases through July 15, 2026. The modified terms cap each advance at $200,000 (up to 9.99% of outstanding shares), price shares at 97% of the lowest 10-day VWAP, and include a True-Up Mechanism that could require additional share issuance if the adjusted price falls below the closing price. This is a dilutive financing arrangement that provides near-term cash but at a significant discount and with potential further dilution.

Actionable Insight

The ELOC draw signals ongoing cash needs and will dilute existing holders at a discount. Monitor the number and size of subsequent advances through July 15, 2026, and watch for any further 8-K filings disclosing additional draws. The True-Up Mechanism adds uncertainty to total dilution — track share count changes in the next 10-Q.

Key Facts

  • Advance Notice submitted June 8, 2026 under SPA dated July 28, 2025, as amended December 22, 2025
  • Per-advance cap of $200,000, up to 9.99% of outstanding shares per notice
  • Purchase price set at 97% of the lowest VWAP over the 10 trading days prior to the advance date
  • True-Up Mechanism may require additional share issuance if 97% of lowest VWAP during the adjustment period is below the closing price
  • Ascent waives mandatory prepayment provisions for payment-upon-delivery advances
  • Advance Notice period runs from June 8, 2026 to July 15, 2026

Financial Impact

Up to $200,000 per advance, with shares sold at a 3% discount to the lowest 10-day VWAP, plus potential additional dilution from the True-Up Mechanism

dilutioncashshare count

Risk Factors

  • Dilution from share issuance at a discount to market price
  • True-Up Mechanism could increase total shares issued beyond the initial advance amount
  • Repeated draws may indicate structural cash burn and difficulty accessing traditional financing

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-066018
Document: 0001213900-26-066018-index-headers.html0001213900-26-066018
Document: 0001213900-26-066018-index.html0001213900-26-066018
Document: 0001213900-26-066018.txt0001213900-26-066018
10 reports for NVACW
Performance horizon
Filters
Rows
Reports for NVACW — sortable, filterable
Type Now
Jun 8, 2026
1d ago
8-K
BEARISH ★ 6/10
awaiting T+20
May 26, 2026
14d ago
8-K
BULLISH ★ 5/10
awaiting T+20
May 15, 2026
25d ago
8-K
NEUTRAL ★ 4/10
awaiting T+20
May 8, 2026
4w ago
8-K
NEUTRAL ★ 4/10
awaiting T+20
May 1, 2026
5w ago
S-1/A
BEARISH ★ 8/10
awaiting T+20
Apr 29, 2026
5w ago
8-K
BEARISH ★ 7/10
awaiting T+20
Apr 28, 2026
6w ago
S-1
BEARISH ★ 8/10
awaiting T+20
Apr 27, 2026
6w ago
8-K
MIXED ★ 5/10
awaiting T+20
Apr 24, 2026
6w ago
8-K
BEARISH ★ 7/10
awaiting T+20
Apr 6, 2026
9w ago
8-K
MIXED ★ 6/10
awaiting T+20
Showing 10 of 10

US Market Status

Market Closed — Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access